Podrobno

Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč : doktorsko delo
ID Humar, Mojca (Avtor), ID Čufer, Tanja (Mentor) Več o mentorju... Povezava se odpre v novem oknu

.pdfPDF - Predstavitvena datoteka, prenos (1,15 MB)
MD5: FC691BCFDFB33501F247F274E20ADF12
PID: 20.500.12556/rul/9136d6e5-a24e-4350-b1cb-75b7537460ae

Jezik:Slovenski jezik
Ključne besede:onkologija, nedrobnocelični karcinom pljuč, receptor za IGF tipa 1, sladkorna bolezen tip 2, stopnja preživetja, imunohistokemija, bioločki tumorski označevalci
Vrsta gradiva:Doktorska disertacija
Tipologija:2.08 - Doktorska disertacija
Organizacija:MF - Medicinska fakulteta
Kraj izida:Ljubljana
Založnik:[M. Humar]
Leto izida:2017
Št. strani:49 f.
PID:20.500.12556/RUL-99262 Povezava se odpre v novem oknu
UDK:616.24-006-036(043.3)
COBISS.SI-ID:293271808 Povezava se odpre v novem oknu
Datum objave v RUL:10.01.2018
Število ogledov:4683
Število prenosov:645
Metapodatki:XML DC-XML DC-RDF
:
HUMAR, Mojca, 2017, Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč : doktorsko delo [na spletu]. Doktorska disertacija. Ljubljana : M. Humar. [Dostopano 12 junij 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=99262
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Ključne besede:oncology, carcinoma non-small-cell lung, receptor IGF type 1, diabetes mellitus type 2, survival rate, immunohistochemistry, biomarkers tumor

Podobna dela

Podobna dela v RUL:
  1. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  2. Antibiotic prescription patterns in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors and their association with treatment outcomes
  3. Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
  4. Characteristics of treatment with proton pump inhibitors among lung cancer patients treated with immunotherapy at the University Clinic Golnik
  5. Prescribing patterns of metformin and paracetamol and their association with treatment outcomes with immune checkpoint inhibitors in patients with non-small cell lung cancer
Podobna dela v drugih slovenskih zbirkah:
  1. Vodnik za bolnike z nedrobnoceličnim pljučnim rakom v stadiju III
  2. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection
  3. Care of patients with non-small-cell lung cancer stage III
  4. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy

Nazaj